戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 228作成日:2026年10月23日

3-methoxy-4-(4-methyl-1H-imidazol-1-yl)aniline → 2-(Isopropoxymethyl)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-4-methyl-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepin-8-amine

https://huagongshe.com/ja/reaction/228

反応式

関与物質

役割名称HCID仕込み量
反応物3-methoxy-4-(4-methyl-1H-imidazol-1-yl)anilineHCID 45480181—
反応物8-Chloro-2-(isopropoxymethyl)-4-methyl-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepineHCID 59577801—
試薬Cesium carbonateHCID 10796—
触媒2-(Dicyclohexylphosphino)biphenylHCID 2734216—
触媒Palladium (II) acetateHCID 4144353—
溶媒1,2-DimethoxyethaneHCID 8071—
生成物2-(Isopropoxymethyl)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-4-methyl-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepin-8-amineHCID 498190945.28%

反応条件

温度100 °C

反応手順

8-chloro-2-(isopropoxymethyl)-4-methyl-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepine (0.157 g, 0.58 mmol), 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)aniline (0.118 g, 0.58 mmol), Palladium acetate (0.013 g, 0.06 mmol), 2-(Dicyclohexylphosphino)biphenyl (0.020 g, 0.06 mmol) and Cesium carbonate (0.567 g, 1.74 mmol) were placed in a microwave vial. The mixture was capped and flushed with argon. 1,2-dimethoxyethane (5 mL) was added and the mixture was run in a microwave for 60 minutes at 100°C. Very little product. Added 0.1 eq ligand and palladium acetate, flushed with argon and run in the microwave at 100°C for 60 min. Still have a lot of startingmaterial (oxazepine) left. Added 0.1 eq ligand and palladium acetate, flushed with argon and run in the microwave at 100°C for 60 min. The reaction mixture was filtrated through Celite and washed with dichloromethane. The filtrate was concentrated and the crude product was purified by preparative chromatography. The productcontaining fractions were pooled, concentrated and the residue was partitioned between sat. NaHCO3 (aq) and dichloromethane. The organic layer was separated by a Phase Separator and concentrated giving 2-(isopropoxymethyl)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-4-methyl-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepin-8-amine (0.013 g, 5.28 %).

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-b387923b7ccc41128cba74368ffb7dd0
出典メモ750 AstraZeneca ELN dataset